AstraZeneca-linked ovarian cancer trial posts results; myeloma follow-up study status reconfirmedNov 13Weekly roundup, 10 itemsAstraZenecaAZD0120Updated
AstraZeneca posts CAPItello-281 results in PTEN-deficient prostate cancer; registers AZD4954 Phase 1Sep 10Weekly roundup, 2 itemsAstraZenecaAZD4954